Effect of Iodine treatment in patiënts with COVID-19 disease.

Phase 2

Recruiting

• Conditions: lunginfection caused by viral infection; 10024970; Viral infection pneumonia; 10047438

• Registration Number: NL-OMON49526
• Lead Sponsor: Maxima Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 224

Inclusion Criteria

Hospitalization and positive test for SARS-CoV-2 infection

Exclusion Criteria

Thyroid disease or treatment like goiter, thyroidectomie, radioactive iodine,
medication related to thyroid dysfunction or the use of Amiodaron

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinically relevant deterioration defined as:<br /><br>1. transfer from regular ward to IC department<br /><br>2. death in regular ward depatment<br /><br>3. death in IC department</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Total number of days in hospital and total number of deaths.</p><br>